Clinical Trial to Demonstrate the Safety and Performance of REGENERA Breast Implant in 40-70 Years Old Women Affected by Malignant Breast Lesion Treated by Lumpectomy
Conditions: Mastectomy, Segmental; Breast Neoplasm Malignant Female Intervention: Device: REGENERA breast implant implantation Sponsor: Tensive SRL Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials
More News: Breast Lumpectomy | Cancer & Oncology | Clinical Trials | Lumpectomy | Mastectomy | Plastic Surgery | Research | Women